Blog

June 26, 2019June 26, 2019

Clinical & Refractive Optometry Appoints Dr. Justin Kwan Editor-in-Chief

Justin Kwan, OD, FAAO, has been appointed in the new role of Editor-in-Chief of Clinical & Refractive Optometry Journal (CRO) effective July 1, 2019.

Dr. Kwan is an accomplished optometric educator, researcher and published author. He is currently a private practice clinician at Professional Eye Care Center in Niles, Illinois.

After graduating from the University of California Berkeley School of Optometry, he completed a dry eye and cornea / contact lens research fellowship and residency at Southern College of Optometry (SCO) where he also taught for seven years as an Assistant and Associate Professor.

At the University Eye Center, Dr. Kwan served as chief of the contact lenses service and directed the dry eye clinic. His professional passions include dry eye, keratoconus, refractive surgery, orthokeratology, myopia control and multifocal contact lenses. Dr. Kwan was recognized in 2018 as a “Young Optometrist of the Year” by the California Optometric Association.

In addition to his experience as a reviewer for many professional journals, he brings a passion for optometric education to his new role, which befits the educational mission of Clinical & Refractive Optometry.

Click HERE for the full press release.

June 25, 2019

Marcolin and adidas Announce License Agreement

Marcolin Group and adidas have entered into a licensing agreement for eyewear products.

The partnership, stretching until 2024, will see the first eyewear products hit the market beginning in 2020. Under the terms of the licensing agreement, Marcolin Group will design, develop, manufacture, market and sell eyewear products under the adidas Badge of Sport and Originals labels.

Innovative manufacturing techniques, high-quality materials and lightness characterize the adidas Badge of Sport eyewear models. These frames are designed to provide a comfortable fit, ensuring the ultimate vision and lens protection.

The Originals collection will be inspired by Street Culture and loyal to the DNA of the adidas Originals Brand, sharing values of creativity and authenticity.

Massimo Renon, CEO of Marcolin Group, affirmed: “Today’s sportwear embraces and influences the entire fashion and accessory industry and we are very excited to begin collaborating with a legendary brand as adidas. This partnership represents a further milestone in our strategic view. We are adding an iconic brand to our portfolio, complementing our presence in the eyewear sporting goods industry. This agreement marks once again Marcolin Group’s targeted company strategy: to join with modern, global and unique brands that leverage their innovative DNA. We feel privileged to work together with adidas and apply their philosophy in eyewear”.

Click HERE for the full press release.

June 25, 2019May 16, 2019

OptikEyeStyle – Calvin Klein CK 19101 (col. 430 Teal)

Thin metal lays the framework for a combo sunglass style reimagined in a soft teardrop shape. The combination browline detail is applied in a gentle curve of teal acetate, the starting point of the matching gradient lenses that give this frame a sophisticated look. The whole look is pulled together with a matching teal temple decor and every last detail has been considered, down to the matching metal nosepads.

Distributed by Marchon: www.marchon.com

June 25, 2019June 25, 2019

FYidoctors Banners First Clinic in Pembroke, ON

FYidoctors announces its expansion into Pembroke, ON with Dr. Vernon Prentice, OD and his staff officially joining the FYidoctors family.

As a second-generation optometrist, Dr. Prentice and his staff remain committed to providing excellence in vision testing, eye health examinations and eyewear products.

“FYidoctors has shown me that after the 37 years I’ve spent in practice, it is possible to operate at the highest level of care without the mental overhead private practice constantly demands,” said Dr. Prentice. “My staffs’ efforts to provide our patients with a positive experience when visiting us for eye care services is perfectly aligned with the internal culture of FYidoctors and is reflected by the recognition they receive for those ‘bend over backwards’ moments.”

Through FYidoctors, customers and patients can still expect exceptional personalized eye care services. Additionally, patients and customers will now have the ability to create custom glasses through the ophthalmic laboratory in Delta, British Columbia and have access to a wide selection of frames and designers exclusively offered by FYidoctors.

“We are excited to welcome Dr. Prentice and his staff into the FYidoctors’ family and to be bannering our first location in Pembroke,” said Dr. Alan Ulsifer, Chairman & CEO of FYidoctors. “It brings us great pride to be given the opportunity to serve a new market and demonstrate our commitment to the eye heath of its residents.”

This acquisition marks the third for FYidoctors in Ontario within the last two months.

Source: FYidoctors

June 25, 2019June 25, 2019

Allergan Acquired by Abbot Labs Spin off, AbbVie Inc.

AbbVie Inc., the pharma spin-off from Abbot Labs and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion.

According to Allergan, the portfolio including medical aesthetics, eye care, CNS and gastrointestinal businesses, will enhance AbbVie’s growth platform and create substantial value for shareholders of both companies.

The strategic rationale cited in the news release is that Allergan’s product portfolio will be enhanced by AbbVie’s commercial expertise and international infrastructure.

Upon completion of the transaction, AbbVie will continue to be incorporated in USA and have its principal executive offices in North Chicago, Illinois and will continue to be led by current chairman and CEO, Richard A. Gonzalez. Two members of Allergan’s Board, including chairman and chief executive officer, Brent Saunders, will join AbbVie’s Board upon completion of the transaction.

Click HERE for the full press release.